As BMI-1 has been assigned an important role in conferring stemness to tumor cells in various types of cancer [31–33], we suggest that targeting BMI-1 in relapsed cancer patients including MM could represent a potential therapeutic strategy. This evidence concerns the gene BMI1 and cancer.